Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer

BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICI) were a major clinical advancement that provided an opportunity to improve the prognosis of patients with non-small cell lung cancer (NSCLC). However, programmed death-ligand-1 (PD-L1) expression does not sufficiently predict ICI efficacy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jeong Uk, Lee, Eunyoung, Lee, Sang-Yun, Cho, Hyeong Jun, Ahn, Dong Hyuck, Hwang, Yongki, Choi, Joon Young, Yeo, Chang Dong, Park, Chan Kwon, Kim, Seung Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183402/
https://www.ncbi.nlm.nih.gov/pubmed/37197639
http://dx.doi.org/10.21037/tlcr-22-633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183402/
https://www.ncbi.nlm.nih.gov/pubmed/37197639
http://dx.doi.org/10.21037/tlcr-22-633

Ejemplares similares